Dan Costin, María González-Cao, Marissa Danielle Rybstein, Robert M. Jotte, Juliette Beaulieu, Eric Zhang, Etah Kurland. "A phase 2/3 study of EIK1001 in combination with pembrolizumab and chemotherapy in participants with stage 4 non–small cell lung cancer (NSCLC) (TeLuRide-008).." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.16_suppl.tps8668